1. "Biology of Blood and Marrow Transplantation"
  2. "Center for Hematologic Malignancies"
  3. "GSK Faculty"
Formats
  1. Meeting Abstract (156)
  2. Journal Article (70)
  3. Correspondence (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Center for Hematologic Malignancies (229)
  2. Department of Medicine (229)
  3. GSK Faculty (229)
  4. Hematologic Malignancies, Division of (200)
  5. Sloan Kettering Institute Faculty (185)
  6. Immunology Program Faculty (179)

More Groups

People
  1. Marcel Van Den Brink (127)
  2. Miguel-Angel Perales (95)
  3. Richard O'Reilly (89)
  4. Sergio Giralt (89)
  5. Esperanza Papadopoulos (72)
  6. Ann Jakubowski (68)

More People

Years
  1. 2020 (20)
  2. 2019 (24)
  3. 2018 (35)
  4. 2017 (19)
  5. 2016 (13)
  6. 2015 (12)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (229)
Publishers
  1. Elsevier Inc. (229)

Results (229)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cryopreservation for all is no option in unrelated stem cell transplantation. Comment on Dholaria B, et al. Securing the graft during pandemic: Are we ready for cryopreservation for all? Biol Blood Marrow Transplant. 2020;26:e145-e146
    Correspondence

    Schmidt, A. H.; Buk, D.; Platz, A.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients
    Meeting Abstract

    Thompson, J.; Ren, Y.; Romero, K.; Lew, M.; Bush, A.; Messina, J.; Jung, S. H.; Miller, J.; Zenko, Z.; Jenq, R. R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Early CD4+ T cell reconstruction as predictor for outcomes after allogeneic hematopoietic cell transplantation in pediatric and young adult patients: A validation cohort analyses
    Meeting Abstract

    Van Roessel, I.; Prockop, S. E.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; Cancio, M.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Chemotherapy and inflammation induced damage of intestinal epithelium is associated with increased T cell chemotaxis
    Meeting Abstract

    Jansen, S. A.; van Hoesel, M.; Mokry, M.; Sierra, L. S.; Takashima, S.; Nieuwenhuis, E. E.; Hanash, A. M.; Lindemans, C. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save